ASX-LISTED The Hydroponics Company (THC) has appointed Katy Williams Day as Product and Regulatory Affairs manager in THC Pharma, a wholly owned subsidiary of THC.
Katy Williams Day, who holds a Master of Pharmacy, brings more than 20 years of pharmaceutical industry experience with major pharmaceutical groups to the role.
She will oversee compliance and regulatory matters across THC Pharma operations and use her experience regulatory body submissions to advance THC Pharma's new product range when its recently acquired pharmaceutical manufacturing facility comes on line.
THC secured management for Australian manufactured medicinal cannabis products.
The appointment follows the arrival of Endoca's medicinal cannabis products in Australia which will be available to patients and healthcare professionals in Australia through the MCMP in Jul.
See more at mcmp.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jun 18
